Guru Jambheshwar University of Science & Technology द्वारा सहेयक प्रोफेसर पदों के लिए भर्ती - हिंदी रोज़गार

Vacancy Circular No:

Guru Jambheshwar University of Science and Technology (GJUST)
द्वारा भर्ती - सहेयक प्रोफेसर

सहेयक प्रोफेसर

रिक्त पदों की संख्या: 14 Posts

शैक्षणिक योग्यता (Educational Qualifications): M.Pharma, M.E/M.Tech, MS, M.Phil/Ph.D

Online applications are invited on the prescribed form for the posts of सहेयक प्रोफेसर in various departments on regular basis.

1. Post Name: सहेयक प्रोफेसर

2. No. of posts of सहेयक प्रोफेसर alongwith reservation: 14

3. Pay Bands: सहेयक प्रोफेसर – Academic Pay Level-10

4. Qualifications:

i) A Master’s degree with 55% marks (or an equivalent grade in a point-scale wherever the grading system is followed) in a concerned/relevant/allied subject from an Indian University, or an equivalent degree from an accredited foreign university.

ii) Besides fulfilling the above qualifications, the candidate must have cleared the National Eligibility Test (NET) conducted by the UGC or the CSIR, or a similar test accredited by the UGC, like SLET/SET or who are or have been awarded a Ph.D. Degree in accordance with the University Grants Commission (Minimum Standards and Procedure for Award of M.Phil./Ph.D. Degree) Regulations, 2009 or 2016 and their amendments from time to time as the case may be exempted from NET/SELT/SET: 

iii) Provided, the candidates registered for the Ph.D. programme prior to July 11, 2009, shall be governed by the provisions of the then existing Ordinances/Bye-laws/Regulations of the Institution awarding the degree and such Ph.D. candidates shall be exempted from the requirement of NET/SELT/SET for recruitment and appointment of सहेयक प्रोफेसर or equivalent positions in Universities/Colleges/institutions subject to the fulfilment of the following conditions:-

a) The Ph.D. degree of the candidate has been awarded in a regular mode;

b) The Ph.D. thesis has been evaluated by at least two external examiners;

c) An open Ph.D. viva voce of the candidate has been conducted;

d) The Candidate has published two research papers from his/her Ph.D. work, out of which at least one is in a refereed journal;

e) The candidate has presented at least two papers based on his/her Ph.D. work in conferences/seminars sponsored/ funded/ supported by the UGC/ICSSR/CSIR or any similar agency.

B. The Ph.D. degree has been obtained from a foreign university/institution with a ranking among top 500 in the World University Ranking (at any time) by any one of the following: (i) Quacquarelli Symonds (QS) (ii) the Times Higher Education (THE) or (iii) the Academic Ranking of World Universities (ARWU) of the Shanghai Jiao Tong University (Shanghai).

(i) Bachelor’s degree in any discipline and Master’s Degree in Business Administration/ PGDM/ C.A./ ICWA/ M.Com. with First Class or equivalent and two years of professional अनुभव after acquiring the degree of Master’s degree.

(ii) If a class/ division is not awarded, minimum of 60% marks in aggregate shall be considered equivalent to first class/ division

(i) B.E./ B.Tech./ B.S./ and M.E./ M.Tech./ M.S. or Integrated M.Tech. in relevant branch with first class or equivalent in any one of the degrees. (ii) If a class/ division is not awarded, minimum of 60% marks in aggregate shall be considered equivalent to first class/ division

(i) First class B.Pharm. with Master’s Degree in Pharmacy(M.Pharm.) in appropriate Branch of specialisation in Pharmacy (qualification must be PCI recognized)

(ii) Two years of teaching अनुभव in PCI approved/ recognized Pharmacy College. 

(iii) The candidate should be registered in the register of pharmacists maintained by a State Pharmacy Council. 

(iv) A PCI recognized Pharm.D degree holder shall also be eligible for the posts of Assistant Professor in the subjects of pathophysiology, pharmacology and pharmacy practice

(v) If a class or division is not awarded at Master level, a minimum of 60% marks in aggregate or equivalent cumulative grade point average shall be considered equivalent to first class or division, as the case may be.

5. ADVT.NO.1/2022